Assessment of Clinical and Economic Effectiveness of Alectinib for Patients With ALK+ Non-Small Cell Lung Cancer Without Previous Experience of Targeted Therapy

Medical Technologies. Assessment and Choice (Медицинские технологии. Оценка и выбор)
doi 10.31556/2219-0678.2019.38.4.087-100

Related search